Schrodinger to Launch Predictive Toxicology Tool in H2

MT Newswires Live
04-15

Schrodinger (SDGR) said Monday it plans to launch its predictive toxicology tool to customers in H2.

The computational tool is targeted to improve the properties of drug development candidates and lessen the risk of development failure related to binding off-target proteins, the company said.

The tool is in line with the plan of the US Food and Drug Administration to wind down animal testing requirement for monoclonal antibodies and other drugs, the company said.

"We believe our computational solutions will play a vital role in significantly reducing the use of animal models in preclinical development," Schrodinger CEO Ramy Farid said.

Price: 25.76, Change: +1.27, Percent Change: +5.19

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10